← The Wire
EBSNYSE
Emergent BioSolutions Inc.
Pharmaceutical Preparations · DE · CIK 1367644
Provides innovative solutions for public health threats through products and contract manufacturing services
$429M
Market cap
$8.46
Last close
-0.8%
1D
+7.8%
5D
695K
Volume
Price · last 39 sessions-0.9%
May 4L $7.75 · H $9.50Jun 29
285
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
SC 13GEMERGENT BIOSOLUTIONS INC.Nov 13, 2024SC 13GCHARLES SCHWAB INVESTMENT MANAGEMENT INCFeb 9, 2024SC 13GSC 13GSep 7, 2023SC 13GSC 13GFeb 10, 2022SC 13GNONEFeb 12, 2021SC 13GSCHEDULE 13GFeb 9, 2017SC 13GSC 13GFeb 17, 2015
Insider Activity
In the 90 days to Dec 5, 2025: 4 sold $842K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 5, 2025 | Richard RonaldDirector | Sell | 14,884 | $11.90 | $177K |
| Dec 5, 2025 | Richard RonaldDirector | Sell | 7,100 | $12.11 | $86K |
| Nov 10, 2025 | Degolyer Donald WDirector | Sell | 17,801 | $10.54 | $188K |
| Nov 7, 2025 | Dayal Sujata TyagiDirector | Sell | 8,552 | $10.00 | $86K |
| Oct 7, 2025 | Glessner ColeenEVP, Quality & Ethics, and CPL | Sell | 30,608 | $10.00 | $306K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance